Zachary Christopher, MD
Orthopaedic Surgery · Phoenix, AZNPI 1134625841
Payments from drug & device makers
Across 96 payments — averaging $278.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Smith+Nephew$7K
- Impactortho, Inc.$6K
- Goode Surgical Inc$4K
- Medical Device Business Services, Inc.$630
- Globus Medical$479
- plus $1K from 8 others
What the payments were for
- Grants$4,05815%
- Travel & lodging$1,3415%
- Food & beverage$7,41228%
- Education$13,93452%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 50 | $7,115 |
| Smith+Nephew | 7 | $7,094 |
| Impactortho, Inc. | 9 | $6,217 |
| Goode Surgical Inc | 9 | $3,918 |
| Medical Device Business Services, Inc. | 2 | $630 |
| Globus Medical(2 entities) | 4 | $479 |
| Johnson & Johnson | 4 | $279 |
| Zimmer Biomet | 4 | $259 |
| Skeletal Dynamics Inc | 2 | $220 |
| Total Joint Orthopedics, Inc. | 1 | $177 |
| Vericel Corporation | 1 | $124 |
| Medtronic | 1 | $115 |
| Avanos Medical | 1 | $100 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$3,759
- NONE$1,477
- T2$598
- VARIAX$309
- REAL INTELLIGENCE$252
- Geminus$220
- Align$220
- IJS$220
- Implate$220
- PELVIS II$166
- PROLAYER$164
- GMRS$164
- Distal Femur Plate System$141
- Journey II$137
- POLARSTEM$137
- TFN ADVANCED$126
- MACI$124
- AEQUALIS PERFORM REVERSED$119
- NANOPASS$116
- SLINGSHOT$116
How this compares
$26,745 in reported general payments places this provider in the 80th percentile of 377 orthopaedic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 35 | $197 |
| Celecoxib | 12 | $190 |
| Ondansetron Hcl | 35 | $145 |
| Tramadol Hcl | 38 | $107 |
| Oxycodone Hcl | 26 | $92 |
| Omeprazole | 28 | $68 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Phoenix
- Joseph GimbelPhoenix$19.4M
- Evan LedermanPhoenix$13.4M
- James ChowPhoenix$6.2M
- Michael McKeePhoenix$3.4M
- Henry ClarkePhoenix$1.9M
- Samuel HarmsenPhoenix$1.1M
- Maegen WallacePhoenix$832K
- Anthony HedleyPhoenix$417K
- Matthew SeidelPhoenix$397K
- David OttPhoenix$380K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.